🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11407+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11407 recruiting trials

Phase 1RecruitingNCT06789107

Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus

👨‍⚕️ Jianhua Mao, PhD, MD, Children's Hospital, Zhejiang University School of Medicine📍 2 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06654596

Efficacy and Safety of Telitacicept in IgAN

🏥 Ruijin Hospital📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06575296

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

👨‍⚕️ Brian Ball, MD, City of Hope Medical Center📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06819293

IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma

🏥 Grit Biotechnology📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06465316

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

👨‍⚕️ Ricardo D Parrondo, Dana-Farber - Harvard Cancer Center LAO📍 14 sites📅 Started Dec 2024View details ↗
RecruitingNCT07003100

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

👨‍⚕️ Christiane Querfeld, City of Hope Medical Center📍 10 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06540963

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

👨‍⚕️ Valerie Brown, MD, PhD, Beat Childhood Cancer📍 11 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06701422

Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery

🏥 Columbia University📍 2 sites📅 Started Dec 2024View details ↗
RecruitingNCT06773988

Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy

🏥 Universitaire Ziekenhuizen KU Leuven📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06313437

Revumenib in Combination With 7+3 + Midostaurin in AML

👨‍⚕️ Richard Stone, MD, Dana-Farber Cancer Institute📍 2 sites📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06735755

A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)

🏥 Beam Therapeutics Inc.📍 3 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06534437

MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)

🏥 Ryvu Therapeutics SA📍 36 sites📅 Started Dec 2024View details ↗
RecruitingNCT06354790

Natural History Study of Children With LAMA2-related Dystrophies

🏥 Institut de Myologie, France📍 4 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06401538

BMB-101 in Absence Epilepsy and DEE

👨‍⚕️ Terence O'Brien, MD, The Alfred📍 5 sites📅 Started Dec 2024View details ↗
RecruitingNCT06089616

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

👨‍⚕️ Ipsen Medical, Director, Ipsen📍 5 sites📅 Started Dec 2024View details ↗
NAEnrolling by InvitationNCT05693571

Engagement in CHildhood-Onset Systemic Lupus

👨‍⚕️ Tamar Rubinstein, MD, MS, Montefiore Medical Center📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06728228

Amnioinfusion for Fetal Renal Failure

🏥 Fetal Care Center, PLLC📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06764524

Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management

👨‍⚕️ Lucia Catani, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06747039

Cannabis Extract in Fibromyalgia Syndrome - the SUNRISE Study

👨‍⚕️ Piercarlo Sarzi Puttini, Medical Doctor, IRCCS Ospedale Galeazzi Sant'Ambrogio📍 1 site📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06650163

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

👨‍⚕️ Robert M Prins, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Dec 2024View details ↗
← PreviousPage 192 of 571Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →